Seeking Alpha

Watson Pharmaceuticals (WPI) agrees to buy Ascent Pharmahealth for A$375M ($396M), turning...

Watson Pharmaceuticals (WPI) agrees to buy Ascent Pharmahealth for A$375M ($396M), turning Watson into the fifth-largest generic pharmaceuticals firm in Australia and the largest in Singapore, while giving the company footholds in Malaysia, Hong Kong, Vietnam and Thailand. The deal will be immediately accretive to 2012 earnings.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs